More importantly, overexpression of PD-L1 can almost abrogate the anti-cancer effect of ZDHHC3 knockdown on Panc 02 pancreatic tumor model, thus targeting ZDHHC3 may be a potential therapeutic approach to enhance anti-tumor immunotherapy. The gene discussed is ZDHHC3; the disease is neoplasm.